Novartis AG named Joe Jimenez, head of the company’s pharmaceuticals division, to take over as chief executive officer from Daniel Vasella effective Feb. 1.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.